Patent landscape and therapeutic evolution of Mazdutide: a dual GLP-1/Glucagon receptor agonist for obesity and type 2 diabetes
Mazdutide illustrates how layered patent strategies integrating molecular design, manufacturability, formulation stability, and clinical use claims can secure durable exclusivity. This approach provides a strategic model for future dual and multi-receptor peptide therapeutics.
Authors
- Mohammed Abdul Fasi (ORCID: https://orcid.org/0000-0003-4514-0851)
Institutions
- King Faisal Specialist Hospital & Research Centre (SA)
Publication Details
- Journal
- Expert Opinion on Therapeutic Patents
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1080/13543776.2026.2645812
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00